v3.26.3
Condensed Statements of Operations - USD ($)
3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
OPERATING EXPENSES    
Research and development $ 4,697,186 $ 993,066
General and administrative 1,071,303 803,619
Total operating expenses 5,768,489 1,796,685
LOSS FROM OPERATIONS (5,768,489) (1,796,685)
OTHER INCOME    
Interest income 25,553 11,627
Other income, net 25,553 11,627
NET LOSS $ (5,742,936) $ (1,785,058)
Net loss per common share/Weighted average common shares outstanding    
Net loss per common share - basic (in dollars per share) $ (0.23) $ (0.1)
Net loss per common share - diluted (in dollars per share) $ (0.23) $ (0.1)
Weighted average common shares outstanding - basic (in shares) 24,786,454 17,082,425
Weighted average common shares outstanding - diluted (in shares) 24,786,454 17,082,425